Researcher.Life Logo

Neurotherapeutics : Impact Factor & More

eISSN: 1878-7479pISSN: 1933-7213

Key Metrics

CiteScore
10
Eigenfactor
0.005 - 0.01
Impact Factor
5 - 10
SJR
Q1Pharmacology
SNIP
1.75
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Neurotherapeutics

Neurotherapeutics Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher SPRINGER
Language English
Frequency Quarterly
General Details
LanguageEnglish
FrequencyQuarterly
Publication Start Year2004
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Neurotherapeutics ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Neurotherapeutics

Current and emerging therapies in IDH-mutant glioma.
  • 1 Oct 2026
  • Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics
Sex-specific considerations in migraine therapy.
  • 15 May 2026
  • Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics
Investigations of remibrutinib in models pertinent to multiple sclerosis.
  • 14 May 2026
  • Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics
Strategic consensus on the clinical translation of advanced therapies in paediatric rare neurological disorders.
  • 13 May 2026
  • Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics
A phase 1, safety, tolerability, and pharmacokinetics study of bisnorcymserine, a highly selective inhibitor of butyrylcholinesterase.
  • 13 May 2026
  • Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics
Pulsed focused ultrasound for seizure suppression: Mechanisms, models, and clinical translation.
  • 12 May 2026
  • Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics
Current and emerging therapies in IDH-mutant glioma.
  • 1 Oct 2026
  • Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics
Sex-specific considerations in migraine therapy.
  • 15 May 2026
  • Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics
Investigations of remibrutinib in models pertinent to multiple sclerosis.
  • 14 May 2026
  • Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics
Strategic consensus on the clinical translation of advanced therapies in paediatric rare neurological disorders.
  • 13 May 2026
  • Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics
A phase 1, safety, tolerability, and pharmacokinetics study of bisnorcymserine, a highly selective inhibitor of butyrylcholinesterase.
  • 13 May 2026
  • Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics
Pulsed focused ultrasound for seizure suppression: Mechanisms, models, and clinical translation.
  • 12 May 2026
  • Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics

FAQs on Neurotherapeutics